Nociceptin/Orphanin FQ Receptor Agonists Attenuate l-DOPA-Induced Dyskinesias

Matteo Marti(University of Ferrara), Michele Morari(University of Ferrara)

Journal of Neuroscience

November 14, 2012

10.1523/jneurosci.6408-11.2012

Cited by 42

Related Papers

Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists

|British Journal of Pharmacology|2017|22

MAM-2201 acute administration impairs motor, sensorimotor, prepulse inhibition, and memory functions in mice: a comparison with its analogue AM-2201

|Psychopharmacology|2023|8

RGS4 negatively modulates Nociceptin/Orphanin FQ opioid receptor signaling: implication for L-Dopa induced dyskinesia

|Unknown|2021|0